FREEDOM - M: Oral Treprostinil as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Clinical trial NCT00325403 · COMPLETED

Trial details

NCT number: NCT00325403
Sponsor: United Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2006-10-01
Primary completion: 2011-04-01
Enrollment: 349

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.